The University of Kentucky Center for Molecular Medicine through the Dean of the College of Medicine and in conjunction with the NIH/NIGMS funded Center of Biomedical Research Excellence (COBRE) grant anticipates funding pilot grants in the amount of $50,000 per year for up to two years.  Research projects should fit into the general theme of the molecular basis of human disease. Three categories of grants will be considered: 

UK Health Care pediatrician Dr. Lindsay B. Ragsdale was recently elected as chair of the Pediatric Special Interest Group for the American Academy of Hospice and Palliative Care Medicine (AAHPM). Ragsdale is the associate director of the Pediatric Advanced Care Team (PACT), which serves families of seriously ill children at Kentucky Children's Hospital (KCH). PACT focuses on improving quality of life, communicating health information to families and managing pain for patients in many sections of the hospital.
ragsdale_lindsayb_008_photo_white_coat.jpg
ragsdale_lindsayb_008_photo_white_coat.jpg

The 2015 Saha Awards application process is now open. 

The application process will close on Monday, June 1, 2015.

Saha Awards 2015.png
Saha Awards 2015.png

The Office of Research within the College of Medicine has the mission of supporting faculty, staff and trainees in all aspects of their research-related endeavors.  This office recently launched a new website to assist with the dissemination of pertinent information.  The website is located within the College of Medicine Research site and can be found by clicking here.   

[From the NHLBI Website]

Charting our future together: NHLBI’s Strategic Visioning Process

 

You may want to consider providing feedback on the NIH proposed Clinical Trials Registration rule. The deadline has been extended to March 23, 2015. To view the release and make comments, click here.

Xiang-An Li, Ph.D., of the University of Kentucky Saha Cardiovascular Research Center and Department of Pediatrics, has been awarded a $3 million grant from the National Institutes of Health to study synthetic HDL (sHDL) as a potential therapy for sepsis. Sepsis -- also called septicemia -- is a life-threatening condition caused by an overwhelming immune response to infection. Immune chemicals released by the body into the bloodstream to fight the infection trigger widespread inflammation that can damage multiple organ systems.
xiang-an.jpg
xiang-an.jpg